Recall
FDAHealthMarch 7, 2025

Exela Pharma Sciences LLC — 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma S

⚠️ Lack of Assurance of Sterility

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 7, 2025

Nationwide

What's affected?

Product
8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4
Lot code
10006417

Additional details

Lots: 10006417 and 10006418, Exp. 11/30/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 103,950 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.